SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 25.710.0%Jan 27 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (12426)12/11/1999 5:09:00 PM
From: aknahow  Read Replies (1) of 17367
 
If this is important news why did XOMA say nothing about it long time ago? Doubt they will have a press release even now. The article was submitted in March, accepted in Sept. and published in December. Is it really news? Did the market discount it? For us it is news and we did not know about it but did the larger players know?

Here is the link to the article should anyone want to see the abstract.

pediatrics.org

Blugreen I think it was an important find. But until the N.Y.Times runs an article explaining to its' readers why this BPI deficiency in newborns is important I am not sure the market will care. Sort of like the anti-agiogenisis story which was old news but became NEW after their article.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext